Genes, Vol. 12, Pages 1156: Harnessing the Nucleolar DNA Damage Response in Cancer Therapy

Genes, Vol. 12, Pages 1156: Harnessing the Nucleolar DNA Damage Response in Cancer Therapy Genes doi: 10.3390/genes12081156 Authors: Jiachen Xuan Kezia Gitareja Natalie Brajanovski Elaine Sanij The nucleoli are subdomains of the nucleus that form around actively transcribed ribosomal RNA (rRNA) genes. They serve as the site of rRNA synthesis and processing, and ribosome assembly. There are 400–600 copies of rRNA genes (rDNA) in human cells and their highly repetitive and transcribed nature poses a challenge for DNA repair and replication machineries. It is only in the last 7 years that the DNA damage response and processes of DNA repair at the rDNA repeats have been recognized to be unique and distinct from the classic response to DNA damage in the nucleoplasm. In the last decade, the nucleolus has also emerged as a central hub for coordinating responses to stress via sequestering tumor suppressors, DNA repair and cell cycle factors until they are required for their functional role in the nucleoplasm. In this review, we focus on features of the rDNA repeats that make them highly vulnerable to DNA damage and the mechanisms by which rDNA damage is repaired. We highlight the molecular consequences of rDNA damage including activation of the nucleolar DNA damage response, which is emerging as a unique response that can be exploited in anti-cancer therapy. In this review, we focus on CX-5461, a novel inhibitor of Pol I transcription that induces the nucleolar DNA da...
Source: Genes - Category: Genetics & Stem Cells Authors: Tags: Review Source Type: research